Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

An allergen testing business based in the US has strengthened its UK operations by opening a new laboratory in Cardiff.

INDOOR Biotechnologies, which has its headquarters in Virginia, set its sights on Cardiff Medicentre in the grounds of the University Hospital of Wales as the home of its new state-of-the-art facility. It will see the company expanding its allergen analysis services and its research and development arm as it enters the next phase of growth.

Dr James Hindley, Scientific Operations Manager, who is heading up the new lab said, “Much of what we will be doing in Cardiff is measuring allergens from species including cat, dog, dustmite, pollen and nuts. Our clients are academic and non-academic researchers, allergen manufacturers, pharmaceutical companies, manufacturers of allergen reduction or management products and food companies based all over the world ho call on us to help detect and work towards minimising the effects of allergens.”

INDOOR’s new facility will also be used to carry out allergy-based research and to develop new products and services including new allergen detection kits which will be sold to allergy sufferers and companies and researchers working in countries including France, Spain and Japan and throughout the UK.

“The scale of our work reflects the ongoing issues allergies present in everyday life, and the strong commercial basis for what we’re doing,” said Hindley. “By creating this new lab, we will be opening up new markets to supplement those already secured by our US parent company.”

The group’s expansion into Wales comes at a time when Welsh life sciences businesses are set to benefit from a £100 million government fund aimed at building on Wales’ growing reputation in this area.

“The progress that’s been made in life sciences and innovation here over the last 1-2 years is impressive and there is a tangible and promising emphasis on helping these companies thrive,” said Hindley.

South Wales born and bred, Hindley studied Biochemistry at Cardiff University, obtaining his PhD at the hospital campus just a stone’s throw away from Cardiff Medicentre. After a spell working at INDOOR’s US headquarters and its UK base in Warminster, Hindley is excited to be bringing the company to Wales.

“On a personal level, I’m thrilled to be back in Cardiff, starting to put something back into the region. I’ll be maintaining close ties with Cardiff University in particular and look forward to recruiting local talent and growing the company with the support of Cardiff Medicentre.”

The business incubation site was chosen as the base for INDOOR’s new facility because of its prime location on the hospital campus, its set-up and the facilities on offer, including part-fitted labs. INDOOR’s fellow tenants at Cardiff Medicentre include the medical devices company Asalus, drug testing business Cansford Laboratories and the ultrasound training company Medaphor.

“It’s hugely inspirational to be working alongside growing businesses which are doing some pretty exciting things,” Hindley said.

Dr Mark Bowman, Director of Innovation at Cardiff Medicentre said, “We’re delighted to welcome James and his team. As a business incubator which supports and nurtures new life science companies, we’re always pleased to see businesses with great ideas, and people with a strong work ethic and plenty of ambition.”

-Ends-

Notes to editors:

About INDOOR Biotechnologies Ltd

Indoor Biotechnologies is an immunodiagnostics and biotechnology company specialising in manufacturing innovative products for investigating allergy and asthma. The company is recognised as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company is also at the forefront of research on allergen structure, molecular biology and immune response. Its mission is to improve the quality of life of patients with allergy and asthma.

Indoor Biotechnologies is privately held and organised as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas. IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand. Indoor Biotechnologies has a global presence, with authorised distributors in Japan, China, South Korea, Australia and New Zealand and sales in 35 different countries. Indoor Biotechnologies is an entrepreneurial company that couples innovative science with a creative approach to business to add value through technology.

About Cardiff Medicentre

Cardiff Medicentre is a dedicated medical, healthcare, and life sciences business incubator located on the University Hospital of Wales campus. The latter is also home to Cardiff University's School of Medicine.

The Cardiff Medicentre Joint Venture was established in 1992 to provide dedicated business incubation facilities for start-up and spin-out companies operating in the medical, healthcare and life sciences sectors. It was the first incubator of its kind in the United Kingdom and provides high quality office and laboratory accommodation comprising 32 units ranging from 284 sq ft to 1,045 sq ft. Low-cost desk leasing facilities are also available to encourage entrepreneurs to enter the Cardiff Medicentre community whilst writing business plans and raising finance.

Examples of successful graduate companies include:

• Q-Chip Ltd (completed $6 million venture capital investment round in 2011)
• Cardiff Bioanalytical Services Ltd (acquired by LGC Ltd in 2010)
• Cardiff Research Consortium (acquired by Capita Group plc for £11.6 million in 2009)
• BioDynamics Research Ltd (acquired by Quotient BioResearch Ltd in 2008)
• Tricho-Tech Ltd (acquired by Concateno plc for £11.25 million in 2007)
• OnExamination Ltd (acquired by BMJ Group in 2007).

Find Cardiff Medicentre on Twitter at twitter.com/cardiff_medi

This press release was distributed by ResponseSource Press Release Wire on behalf of Vitis Public Relations in the following categories: Business & Finance, Medical & Pharmaceutical, Construction & Property, for more information visit https://pressreleasewire.responsesource.com/about.